Cargando…
Colon cancer cells produce immunoregulatory glucocorticoids
Expression or release of immunosuppressive molecules may protect tumor cells from the recognition and destruction by the immune system. New findings indicate that colorectal tumors produce immunoregulatory glucocorticoids and thereby suppress immune cell activation. The nuclear receptor LRH-1 plays...
Autores principales: | Sidler, Daniel, Renzulli, Pietro, Schnoz, Christina, Berger, Barbara, Schneider-Jakob, Sabine, Flück, Christa, Inderbitzin, Daniel, Corazza, Nadia, Candinas, Daniel, Brunner, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382911/ https://www.ncbi.nlm.nih.gov/pubmed/22754774 |
Ejemplares similares
-
Endogenous and exogenous glucocorticoids abolish the efficacy of immune-dependent cancer therapies
por: Ma, Yuting, et al.
Publicado: (2019) -
Human lung carcinomas synthesize immunoregulatory glucocorticoids
por: Merk, Verena M., et al.
Publicado: (2023) -
Gut microbiota and colon cancer: the carbohydrate link
por: Belcheva, Antoaneta, et al.
Publicado: (2014) -
Induction of pyroptosis in colon cancer cells by LXRβ
por: Rébé, Cédric, et al.
Publicado: (2015) -
PTPN2 as a promoter of colon carcinoma via reduction of inflammasome activation
por: Spalinger, Marianne R., et al.
Publicado: (2018)